List of Soluprep drug patents

Soluprep is owned by 3M Health Care.

Soluprep contains Chlorhexidine Gluconate; Isopropyl Alcohol.

Soluprep has a total of 1 drug patent out of which 0 drug patents have expired.

Soluprep was authorised for market use on 08 August, 2018.

Soluprep is available in solution;topical dosage forms.

Soluprep can be used as for the preparation of skin prior to surgery; helps reduce bacteria that can potentially cause skin infection.

The generics of Soluprep are possible to be released after 26 July, 2029.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8623935 3M HEALTH CARE Antimicrobial compositions
Jul, 2029

(6 years from now)

Drugs and Companies using CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL ingredient

Market Authorisation Date: 08 August, 2018

Treatment: For the preparation of skin prior to surgery; Helps reduce bacteria that can potentially cause skin infection

Dosage: SOLUTION;TOPICAL

More Information on Dosage

SOLUPREP family patents

3

United States

2

China

2

European Union

1

Japan

1

Brazil

1

Canada

1

Australia

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in